期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 61, 期 6, 页码 478-486出版社
ELSEVIER
DOI: 10.1016/j.addr.2009.03.008
关键词
Nanotechnology; Nanopharmaceuticals; Nanoparticles; Dendrimers; Fullerenes; Carbon nanotubes; Metal oxide nanoparticles; Copper nanoparticles
The lack of correlative and predictive models to assess acute and chronic toxicities limits the rapid preclinical development of new therapeutics. This barrier is due in part to the exponential growth of nanotechnology and nanotherapeutics, coupled with the lack of rigorous and robust screening assays and putative standards. It is a fairly simple and cost-effective process to initially screen the toxicity of a nanomaterial by using in vitro cell cultures; unfortunately it is nearly impossible to imitate a complimentary in vivo system. Small mammalian models are the most common method used to assess possible toxicities and biodistribution of nanomaterials in humans. Alternatively, Dania rerio, commonly known as zebrafish, are proving to be a quick, cheap, and facile model to conservatively assess toxicity of nanomaterials. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据